Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.


TSX:SVA - Post by User

Comment by Redbaron2211on Feb 04, 2021 5:02pm
141 Views
Post# 32479277

RE:Nasdaq requirements

RE:Nasdaq requirementsSteadfast I have looked at the requirements in the past.  From my understanding we would qualify for the Equity Standard or Market Value standard and would not need to worry about the Net income standard; you only need to qualify for 1 not all 3.   I haven't dug into it enough to see if there are even lower standards for canadian companies but if there is then great.  A reverse split has to be taken into context IMO its not always negative especially if being done for a nasdaq listing.  

It's the institutional backing that makes these things happen and that's onboarding right now as nervous retail jump ship thats generally how its goes as a company makes a big transition like this.  Anyways all my opinion take it how you like. 

Bio with the right backing sva wont have a problem matching peer valuation on Nasdaq.  
<< Previous
Bullboard Posts
Next >>